Literature DB >> 29201222

Contrast-enhanced ultrasound is better than magnetic resonance imaging in evaluating the short-term results of microwave ablation treatment of uterine fibroids.

Yan Zhang1, Meiwu Zhang1, Xiaoxiang Fan1, Dafeng Mao1.   

Abstract

Contrast-enhanced ultrasound (CEUS) and magnetic resonance imaging (MRI) were compared in evaluating the short-term effects of microwave ablation (MWA) on uterine fibroids. A total of 60 patients with uterine fibroids treated by MWA were enrolled in the experimental group during their two-year follow-up period according to the inclusion criteria. Conventional two-dimensional US, MRI and CEUS were performed to determine the volume reduction and the fibroid residue by displaying the size, echo and signal intensity of fibroids prior to and after MWA treatment. As the control group, 60 consecutive patients were recruited on their follow-up visit at least two years after MWA treatment of uterine fibroids. Significant differences were observed in the wash-in rate (WiR) of the fibroid tissue, start time difference, rise time ratio (RTR) and WiR ratio between the experimental and control groups (P<0.05). However, the WiR of fibroid vessel, total area under the curve of fibroid vessel and tissue, and rise time difference (RTD) between fibroid vessel and tissue did not display any significant differences between the two groups. Fibroids were either reduced in volume or cured by MWA therapy in patients with uterine fibroids. The reductions in volume of hypointense, isointense and hyperintense fibroids were 62.42±18.13, 53.27±10.05 and 47.43±9.56%, respectively, on T1-weighted imaging (T1WI). On T2WI, the corresponding reductions were 67.32±32.63, 59.36±19.36 and 42.63±10.37%, respectively. The higher the signal intensity on T1WI and T2WI, the lower the reduction in volume. It is indicative that different blood supply to fibroids results in different ablation. CEUS was proved to be more effective than MRI in evaluating the effects of MWA on uterine fibroids during the first postoperative year.

Entities:  

Keywords:  contrast-enhanced ultrasound; magnetic resonance imaging; microwave ablation; uterine fibroids

Year:  2017        PMID: 29201222      PMCID: PMC5704341          DOI: 10.3892/etm.2017.5171

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  14 in total

1.  Imaging manifestation of conventional and contrast-enhanced ultrasonography in percutaneous microwave ablation for the treatment of uterine fibroids.

Authors:  Fang Wang; Jing Zhang; Zhi-Yu Han; Zhi-Gang Cheng; Hong-Yu Zhou; Lei Feng; Dong-Mei Hu
Journal:  Eur J Radiol       Date:  2012-02-16       Impact factor: 3.528

2.  Severe life-threatening hemoperitoneum from posttraumatic avulsion of a pedunculated uterine leiomyoma.

Authors:  S Estrade-Huchon; P Bouhanna; O Limot; A Fauconnier; G Bader
Journal:  J Minim Invasive Gynecol       Date:  2010 Sep-Oct       Impact factor: 4.137

3.  Extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: imaging and histopathologic evaluation.

Authors:  Xiao-Long Ren; Xiao-Dong Zhou; Jun Zhang; Guang-Bin He; Zeng-Hui Han; Min-Juan Zheng; Li Li; Ming Yu; Lei Wang
Journal:  J Ultrasound Med       Date:  2007-02       Impact factor: 2.153

4.  Ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroid treatment--a clinical study.

Authors:  Jing Zhang; Lei Feng; Bingsong Zhang; Jintao Ren; Zhencai Li; Dongmei Hu; Xue Jiang
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

5.  Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography.

Authors:  Xiao Dong Zhou; Xiao Long Ren; Jun Zhang; Guang Bin He; Min Juan Zheng; Xue Tian; Li Li; Ting Zhu; Min Zhang; Lei Wang; Wen Luo
Journal:  Eur J Radiol       Date:  2007-01-26       Impact factor: 3.528

6.  [Long-term results of percutaneous sonographically-guided microwave ablation therapy of early-stage hepatocellular carcinoma].

Authors:  Bao-wei Dong; Ping Liang; Xiao-ling Yu; De-jiang Yu; Jing Zhang; Lei Feng; Zhi-gang Cheng; Yang Wang; Zhi-li Wang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2006-03-28

7.  Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas.

Authors:  Fabio Ghezzi; Antonella Cromi; Valentino Bergamini; Stefano Scarperi; Pierfrancesco Bolis; Massimo Franchi
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

8.  MRI guidance of focused ultrasound therapy of uterine fibroids: early results.

Authors:  Jonathan Hindley; Wladyslaw M Gedroyc; Lesley Regan; Elizabeth Stewart; Clare Tempany; Kullervo Hynyen; Kullervo Hynnen; Nathan Mcdannold; Nathan Macdanold; Yael Inbar; Yacov Itzchak; Jaron Rabinovici; Hyun S Kim; Kevin Kim; Jean-François Geschwind; Gina Hesley; Bobbie Gostout; Brian Gostout; Tillman Ehrenstein; Sylvia Hengst; Miri Sklair-Levy; Asher Shushan; Ferenc Jolesz
Journal:  AJR Am J Roentgenol       Date:  2004-12       Impact factor: 3.959

9.  Ultrasound-guided radiofrequency thermal ablation of uterine fibroids: medium-term follow-up.

Authors:  Gianpaolo Carrafiello; Chiara Recaldini; Federico Fontana; Fabio Ghezzi; Salvatore Cuffari; Domenico Laganà; Carlo Fugazzola
Journal:  Cardiovasc Intervent Radiol       Date:  2009-09-24       Impact factor: 2.740

Review 10.  Long-term intermittent pharmacological therapy of uterine fibroids - a possibility to avoid hysterectomy and its negative consequences.

Authors:  Anita Olejek; Katarzyna Olszak-Wąsik; Anna Czerwinska-Bednarska
Journal:  Prz Menopauzalny       Date:  2016-03-29
View more
  2 in total

1.  Contrast-Enhanced Ultrasound Imaging of Uterine Disorders: A Systematic Review.

Authors:  Barbara Stoelinga; Lynda Juffermans; Anniek Dooper; Marleen de Lange; Wouter Hehenkamp; Thierry Van den Bosch; Judith Huirne
Journal:  Ultrason Imaging       Date:  2021-05-26       Impact factor: 1.578

2.  Ultrasound-guided high-intensity focused ultrasound in the treatment of uterine fibroids.

Authors:  Hong-Jie Fan; Chao Zhang; Hong-Tao Lei; Jiang-Ping Cun; Wei Zhao; Jian-Qiang Huang; Yue Zhai
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.